Matt Holliday has been an outspoken critic of players who have used performance-enhancing drugs.
He is willing to forgive and forget when it comes to Jhonny Peralta, his new St. Louis Cardinals teammate.
The Cardinals' new shortstop was suspended last summer along as part of Major League Baseball's investigation into the Biogenesis clinic.
Peralta served a 50-game drug suspension and returned to the Tigers at the end of the regular season before signing a $53 million, four-year contract with St. Louis in November.
Holliday says Peralta served his suspension and welcomes him to the team.